Clozapine Does NOT Decrease Appetite—It Typically Increases It
No, clozapine (Clozaril) does not decrease appetite; rather, it is strongly associated with increased appetite and significant weight gain, which is one of its most concerning metabolic adverse effects. 1
Weight Gain and Metabolic Effects
The most recent global consensus guidelines from 2026 explicitly address clozapine's metabolic profile, emphasizing that weight gain and metabolic syndrome are major adverse drug reactions requiring systematic monitoring 1. The guidelines mandate:
- Biometric monitoring every 3 months: weight, waist circumference, blood pressure, and heart rate
- Metabolic blood tests every 6-12 months: HbA1c, fasting glucose, triglycerides, and HDL cholesterol
- Active treatment of metabolic complications when detected, including lifestyle interventions and pharmacological options like metformin, GLP-1 receptor agonists, and aripiprazole 1
This intensive monitoring protocol exists precisely because clozapine causes weight gain and increased appetite, not appetite suppression.
The Rare Exception: Weight Loss
While weight gain is the norm, weight loss with clozapine is rare and should prompt clinical investigation 2, 3. When it occurs, consider:
- Clozapine-induced dysphagia: Can cause significant difficulty swallowing, leading to reduced intake and substantial weight loss (up to 20% of body weight) 2
- Gastrointestinal hypomotility: Severe constipation or ileus may reduce appetite secondarily 1
- Poor treatment response: Some case reports suggest weight loss may indicate inadequate therapeutic response 3
Clinical Pitfall
If a patient on clozapine loses weight, do not assume this is a beneficial effect. Investigate for:
- Dysphagia (assess swallowing function, consider modified diet or Mendelsohn maneuver technique) 2
- Severe constipation or gastrointestinal hypomotility (the leading cause of clozapine-related death) 1
- Underlying medical conditions
- Inadequate clozapine response 3
Mechanism of Appetite Effects
Research shows clozapine's effects on appetite-regulating peptides are complex. One study found negative correlations between clozapine concentration and neuropeptide Y (NPY), and between clozapine dose and leptin 4, but these findings do not translate to decreased appetite in clinical practice. The overwhelming clinical reality is weight gain and increased food intake 5.
The standard expectation with clozapine is weight gain requiring proactive metabolic monitoring and intervention, not appetite suppression.